General Information of Drug (ID: DMEZGRX)

Drug Name
Vismed
Indication
Disease Entry ICD 11 Status REF
Eye disorder 9A01-9A0Z Phase 4 [1]
Cross-matching ID
TTD ID
D07NLI

References

1 ClinicalTrials.gov (NCT02117687) A Safety and Efficacy Study of OPTIVE FUSION With VISMED Multi for the Management of Dry Eye. U.S. National Institutes of Health.